InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by ANDREWS DEBORAH J, Director. Officer active across 1 companies, notably Lineage Cell Therapeutics, Inc.. In total, 2 reports have been published. The latest transaction was filed on 29 June 2021 — Levée d'options. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations2 total
€45,69324,720 shares@ €1.8484100.0% of flow
Common Shares, no par value
SEC:0001493152-21-015788·
€45,69324,720 shares@ €1.84840.011% mcap50.0% of flow
Common Shares, no par value
SEC:0001493152-21-015788:0·
2 of 2 declarations
About ANDREWS DEBORAH J
ANDREWS DEBORAH J is a Board Member of Lineage Cell Therapeutics, Inc. She brings expertise in the biotechnology and healthcare sector. As a board member, Deborah plays a key role in the governance of the company and in making strategic decisions. Her experience in the medical field is an asset for innovation and growth at Lineage.
